Paper25759780
Comparison of sirolimus and colchicine treatment on the development of peritoneal fibrozis in rats having peritoneal dialysis.
Sağıroğlu T and 6 others. Balkan Med J, 2015. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. Comparison of sirolimus and colchicine treatment on the development of peritoneal fibrozis in rats having peritoneal dialysis. Papers, record 25759780. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/25759780
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Comparison of sirolimus and colchicine treatment on the development of peritoneal fibrozis in rats having peritoneal dialysis.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References29
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 16597691 | Mammalian target of rapamycin pathway blockade slows progression of diabetic kidney disease in rats. | J Am Soc Nephrol | 2006 | https://conductscience.org/library/papers/16597691 | PubMed |
| 2 | 16048249 | Effects of inhibition of the polyol pathway during chronic peritoneal exposure to a dialysis solution. | Perit Dial Int | 2005 | https://conductscience.org/library/papers/16048249 | PubMed |
| 3 | 3287167 | Colchicine in the treatment of cirrhosis of the liver. | N Engl J Med | 1988 | https://conductscience.org/library/papers/3287167 | PubMed |
| 4 | 3537784 | A prospective trial of colchicine for primary biliary cirrhosis. | N Engl J Med | 1986 | https://conductscience.org/library/papers/3537784 | PubMed |
| 5 | 9845827 | Persistent transforming growth factor-beta 1 expression may predict peritoneal fibrosis in CAPD patients with frequent peritonitis occurrence. | Am J Nephrol | 1998 | https://conductscience.org/library/papers/9845827 | PubMed |
| 6 | 16204281 | ESRD patients in 2004: global overview of patient numbers, treatment modalities and associated trends. | Nephrol Dial Transplant | 2005 | https://conductscience.org/library/papers/16204281 | PubMed |
| 7 | 19244201 | Rapamycin prevents transforming growth factor-alpha-induced pulmonary fibrosis. | Am J Respir Cell Mol Biol | 2009 | https://conductscience.org/library/papers/19244201 | PubMed |
| 8 | 16048248 | Transforming growth factor-beta: importance in long-term peritoneal membrane changes. | Perit Dial Int | 2005 | https://conductscience.org/library/papers/16048248 | PubMed |
| 9 | 18751736 | Peritoneal morphologic changes in a peritoneal dialysis rat model correlate with angiopoietin/Tie-2. | Pediatr Nephrol | 2009 | https://conductscience.org/library/papers/18751736 | PubMed |
| 10 | 20448020 | The pathophysiology of the peritoneal membrane. | J Am Soc Nephrol | 2010 | https://conductscience.org/library/papers/20448020 | PubMed |
| 11 | 18981396 | Development of a peritoneal sclerosis rat model using a continuous-infusion pump. | Perit Dial Int | 2008 | https://conductscience.org/library/papers/18981396 | PubMed |
| 12 | 17567474 | Molecular mechanisms of hepatic fibrogenesis. | J Gastroenterol Hepatol | 2007 | https://conductscience.org/library/papers/17567474 | PubMed |
| 13 | 8494931 | The effect of peritoneal dialysis fluid on the release of IL-1 beta and TNF alpha by macrophages/monocytes. | Perit Dial Int | 1993 | https://conductscience.org/library/papers/8494931 | PubMed |
| 14 | 17728765 | Rapamycin: something old, something new, sometimes borrowed and now renewed. | Clin Pharmacol Ther | 2007 | https://conductscience.org/library/papers/17728765 | PubMed |
| 15 | 15770925 | Angiotensin II mediates high glucose-induced TGF-beta1 and fibronectin upregulation in HPMC through reactive oxygen species. | Perit Dial Int | 2005 | https://conductscience.org/library/papers/15770925 | PubMed |
| 16 | 21148060 | Use of angiotensin II inhibitors in patients that develop encapsulating peritoneal sclerosis. | Perit Dial Int | 2010 | https://conductscience.org/library/papers/21148060 | PubMed |
| 17 | 16526322 | The effect of colchicine on the peritoneal membrane. | Ren Fail | 2006 | https://conductscience.org/library/papers/16526322 | PubMed |
| 18 | 18094032 | Low-dose mTOR inhibition by rapamycin attenuates progression in anti-thy1-induced chronic glomerulosclerosis of the rat. | Am J Physiol Renal Physiol | 2008 | https://conductscience.org/library/papers/18094032 | PubMed |
| 19 | 11406650 | Effect of p27 deficiency and rapamycin on intimal hyperplasia: in vivo and in vitro studies using a p27 knockout mouse model. | Lab Invest | 2001 | https://conductscience.org/library/papers/11406650 | PubMed |
| 20 | 11098928 | Encapsulating peritoneal sclerosis: definition, etiology, diagnosis, and treatment. International Society for Peritoneal Dialysis Ad Hoc Committee on Ultrafiltration Management in Peritoneal Dialysis. | Perit Dial Int | 2000 | https://conductscience.org/library/papers/11098928 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 30982374 | Comparison of anti-peritoneal fibrotic effects between an mTORC1-specific blocker and a PI3K/mTOR dual-blocker. | Ren Fail | 2019 | https://conductscience.org/library/papers/30982374 | PubMed |
| 30972175 | Rapamycin inhibits peritoneal fibrosis by modifying lipid homeostasis in the peritoneum. | Am J Transl Res | 2019 | https://conductscience.org/library/papers/30972175 | PubMed |
| 26708182 | Effects of hyperthyroidism on expression of vascular endothelial growth factor (VEGF) and apoptosis in fetal adrenal glands. | Eur J Histochem | 2015 | https://conductscience.org/library/papers/26708182 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/25759780
GET https://conductscience.org/api/papers/v1/25759780/references?page=2